# Shenzhen Oriental Pharmaceutical Co Ltd – FDA Inspection, Jan 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/shenzhen-oriental-pharmaceutical-co-ltd/a3857e9b-ef9d-45e0-8bf3-00a592e74f77
Source feed: FDA_Inspections

> FDA inspection 1080368 of Shenzhen Oriental Pharmaceutical Co Ltd, January 11, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1080368
- Company Name: Shenzhen Oriental Pharmaceutical Co Ltd
- Inspection Date: 2019-01-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1258257 - 2024-11-29](https://www.keypedia.com/records/fda_inspections/shenzhen-oriental-pharmaceutical-co-ltd/f01fc07d-9b71-4d40-9aa8-b0593939811d)
- FDA Inspection 976107 - 2016-06-07
- FDA Inspection 872742 - 2014-03-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/shenzhen-oriental-pharmaceutical-co-ltd/71227651-964f-4f33-a24b-5c0b0f6c92a0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c